Bacteroidales

This test counts bacterial DNA from one of the dominant groups living in your large intestine. In healthy adults these bacteria are usually abundant, and the particular species someone carries can remain fairly stable for months to years.

That stability is what makes the measurement interesting. When the number moves, something may have changed: antibiotics, a gut infection, active inflammation, or how fast stool is moving through the colon. This is a research-grade measurement without standardized clinical cutoffs, so the useful signal is your own trend, not a single number compared with a population range.

What the Test Actually Counts

What the lab counts is bacterial DNA rather than anything your own body makes. The target is usually a stretch of genetic code called the 16S ribosomal RNA gene. PCR is the lab method that copies that stretch many times so it can be counted.

This group is an order, a broad rank that sits above family and genus and below phylum. It contains Bacteroides, Prevotella, Parabacteroides, Porphyromonas, and others. Some are helpful fiber fermenters. A few behave more like opportunists. Counting them together deliberately blurs that distinction.

That matters for how you read your result. An order-level number tells you about the overall size and stability of this bacterial group, not whether any particular member is helping or hurting you.

Inflammatory Bowel Disease

The strongest human evidence is in inflammatory bowel disease, and it cuts in two directions. In children and young adults with inflammatory bowel disease, intestinal biopsies showed reduced diversity of species in this order, especially in more inflamed tissue. That study measured bacteria attached to biopsy tissue, not stool DNA, so it is related evidence rather than the same specimen type.

Other work in active inflammatory bowel disease used stool profiling and found a low-cell-density community pattern dominated by Bacteroides. Total bacteria fell, while Bacteroides made up a bigger slice of a smaller pie.

Both can be true. Many studies report relative abundance. Relative abundance is the percentage of whatever bacteria happen to be present. If the overall bacterial population collapses and this group survives better than its neighbors, the percentage can rise even while the absolute count falls. Without knowing whether your lab reports an absolute count or a percentage, a shift in either direction is ambiguous on its own.

After Antibiotics

Antibiotics are one of the most reliable ways to disrupt this measurement, but the direction depends on the drug. In 1,413 adults, antimicrobial drugs shifted gut microbiome composition, with the strength and duration depending on drug class. Drugs with strong activity against oxygen-avoiding gut bacteria were linked to larger shifts in Bacteroidetes, the wider branch of the bacterial family tree that contains this order, while other classes can make Bacteroidetes look higher as a percentage. Short courses can reduce overall diversity within days.

Recovery afterward is not random. In adults given antibiotics, the starting state of the microbiome helped predict how it was reshaped. Work on Bacteroides vulgatus and Bacteroides uniformis also found that strain competition inside the gut can influence which strain re-establishes dominance.

If you have recently taken antibiotics, a single reading tells you where you are in recovery. It does not tell you your baseline.

Gut Infections and Parasites

Clostridioides difficile infection is usually marked by loss of normal anaerobic gut bacteria, including Bacteroidetes and Bacteroides, compared with healthy groups. That finding is one reason fecal microbiota transplant can work in recurrent infection: it restores a broader donor-like community, including Bacteroidetes and Clostridium groups.

Colonization with the single-celled intestinal parasites Blastocystis and Dientamoeba fragilis has been linked to lower Bacteroides and higher Prevotella. Both are inside this order, so an order-level count can miss the reorganization underneath. A retrospective cohort of 27,918 adults found that a positive stool PCR for either parasite was not associated with the clinical outcomes measured, so a shifted microbial profile alongside one of these organisms does not by itself mean you are sick.

Colorectal Cancer and the Toxin-Producing Strain

One member of this order has a specific cancer connection worth separating from the rest. Enterotoxigenic Bacteroides fragilis carries the bft gene, which lets it make a toxin that can damage the colon lining. A meta-analysis found this strain more often in people with colorectal cancer than in healthy controls, with lower detection in stage I and II disease than in stage III and IV.

An order-level count cannot tell you whether you carry this strain. Detecting it requires PCR aimed specifically at the bft gene, which is a different test.

Whether the broader group causes cancer is a weaker question. Mendelian randomization tests whether inherited differences linked to a trait also track with disease. One such analysis found an initial link between presence of an unclassified group in this order and colorectal cancer risk, but the authors warned that the result was complex and not enough to prove causation.

Metabolic and Liver Disease

In nonalcoholic fatty liver disease, genus-level Bacteroides abundance was independently associated with the more inflamed form of the disease and with meaningful liver scarring in one biopsy-confirmed cohort. A systematic review and meta-analysis across multiple cohorts did not find Bacteroides among the consistent bacterial signatures of the condition, which tells you the finding does not replicate cleanly everywhere.

Community-pattern work has linked Bacteroides-dominant and Prevotella-dominant gut clusters to higher odds of obesity and diabetes in a Japanese cohort. In type 2 diabetes, one small cross-sectional study of 93 people found low Bacteroides abundance associated with worse blood vessel function. Direction of effect is not settled here, and neither is whether the bacteria are driving anything or simply reflecting diet and metabolic state.

Immune Activation and HIV

In people with HIV, order-level stool PCR correlated with activated CD8 T cells in the blood. These are immune cells that stay switched on during chronic infection. The study was small, with 16 HIV-positive subjects, so treat it as a signal that gut community structure and systemic immune state are connected, not as a usable clinical number.

Genetic Evidence, and Its Limits

Mendelian randomization studies have produced a few specific findings. Genetically predicted order-level Bacteroidales was associated with about 28% higher odds of type 1 diabetes. A separate periodontitis analysis linked a family-level Bacteroidales S24-7 group, not the whole order, with about 22% higher odds of periodontitis.

These are estimates from population genetics, not from anyone's stool test. They say something about broad biological links; they do not tell you what your individual reading means for your risk.

Why a Single Reading Can Fool You

Start with the biggest confounder, because it swamps most of the disease signals above. Stool consistency, which reflects how fast material moves through your colon, correlates strongly with gut microbiome richness, composition, community type, and bacterial growth rates. A looser stool from a stomach bug, a big dose of magnesium, or a travel week can shift your result without anything meaningful changing about your gut health.

• Transit time and stool water: faster transit and wetter stool change which groups dominate. This is ordinary physiology, not disease, and it is the most common way a commercial panel can misread a normal gut as out of balance.
• Recent antibiotics: effects can persist for months and vary by drug class. Any reading within several months of a course reflects recovery, not baseline.
• Which DNA target the lab amplifies: results differ depending on primer choice and target region. Two labs can report different numbers from the same sample.
• Extraction kit and lab: a multicenter quality assessment found high variability between centers analyzing identical material, with primer choice the largest single factor. Do not compare a result from one lab against a result from another.

There is one more limit worth naming. PCR detects DNA, not living organisms. A positive or elevated signal cannot distinguish a thriving population from residual genetic material, which is why molecular stool results are normally interpreted alongside symptoms rather than on their own.

Why One Reading Is Not Enough

Daily quantitative sampling of healthy adults found substantial temporal variation in 78% of gut microbial genera, with stool moisture and diet among the drivers. A one-year study of 75 people found that within-person variation accounted for 23% of total variance in gut composition. You are a moving target, and so is your number.

Against that noise, one measurement is close to meaningless. A series is not. The species within this order can show long-term stability in the same person, so a sustained departure from your own established pattern carries information that a single reading never can.

Compare samples only when they were collected under similar conditions: same lab, same assay, normal stool form, and well away from recent antibiotics. Comparing a formed-stool sample to a loose-stool sample from a different lab tells you about the collection conditions, not about your gut.

What to Do With an Out-of-Pattern Result

An unexpected number is a prompt to look at the rest of the picture, not a diagnosis. Work outward from what would actually change your decisions.

If you have digestive symptoms alongside the shift, fecal calprotectin is the companion test that matters most. It measures a protein released by immune cells in the gut wall and helps separate gut-lining inflammation from a non-inflammatory problem, which a DNA count cannot do. Pancreatic elastase tells you whether you are digesting fat properly. A pathogen panel rules out the treatable infections that reshape this community in the first place.

If you have no symptoms and the shift is modest, the most likely explanation is stool consistency, recent diet, or assay variation. Repeat under controlled conditions before doing anything else.

Certain combinations justify escalating. Persistent blood in the stool, unexplained weight loss, iron-deficiency anemia, or a family history of colorectal cancer are reasons to pursue colonoscopy and to consider testing specifically for the toxin-producing Bacteroides fragilis strain, regardless of what your order-level number shows. Elevated calprotectin with ongoing diarrhea belongs with a gastroenterologist. A microbiome result alone is not a reason for either.